2seventy bio Inc.

NASDAQ: TSVT · Real-Time Price · USD
5.00
0.00 (0.00%)
At close: May 12, 2025, 3:59 PM

2seventy bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
37.86M 100.39M 91.5M 54.52M
Cost of Revenue
22.56M 16.92M 26.22M 12.59M
Gross Profit
15.3M 83.47M 65.28M 41.93M
Operating Income
-115.43M -237.61M -262.91M -313.51M
Interest Income
10.88M 12.41M 2.93M 88K
Pretax Income
-57.25M -217.57M -254.15M -292.21M
Net Income
-57.25M -217.57M -254.14M -276.21M
Selling & General & Admin
43.92M 69.41M 79.45M 93.51M
Research & Development
76.92M 230.76M 248.74M 261.94M
Other Expenses
9.89M 20.91M n/a n/a
Operating Expenses
130.73M 321.08M 328.19M 355.44M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
153.29M 338M 354.4M 368.03M
Income Tax Expense
n/a n/a -8.99K -16M
Shares Outstanding (Basic)
52.22M 49.28M 35.64M 23.59M
Shares Outstanding (Diluted)
52.22M 49.28M 35.64M 23.59M
EPS (Basic)
-1.1 -4.42 -7.13 -11.71
EPS (Diluted)
-1.1 -4.42 -7.13 -11.71
EBITDA
-98.45M -206.42M -251.38M -297.16M
EBIT
-105.54M -216.7M -262.91M -313.51M
Depreciation & Amortization
7.1M 10.29M 11.53M 16.4M